vs
Fat Brands, Inc（FAT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Fat Brands, Inc的1.6倍（$219.9M vs $140.0M），Orthofix Medical Inc.净利率更高（-1.0% vs -41.6%，领先40.6%），Orthofix Medical Inc.同比增速更快（2.0% vs -2.3%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-16.9M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -6.1%）
FAT Brands是来自美国的多品牌餐饮与体育酒吧连锁运营商，总部位于加利福尼亚州比弗利山庄，主要开展餐饮品牌的连锁加盟运营业务，旗下涵盖多个餐饮及休闲体育酒吧品牌。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FAT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.6倍
$140.0M
营收增速更快
OFIX
高出4.3%
-2.3%
净利率更高
OFIX
高出40.6%
-41.6%
自由现金流更多
OFIX
多$33.7M
$-16.9M
两年增速更快
OFIX
近两年复合增速
-6.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $140.0M | $219.9M |
| 净利润 | $-58.2M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | -12.4% | 0.2% |
| 净利率 | -41.6% | -1.0% |
| 营收同比 | -2.3% | 2.0% |
| 净利润同比 | -30.1% | 92.4% |
| 每股收益（稀释后） | $-3.39 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FATOFIX
| Q4 25 | — | $219.9M | ||
| Q3 25 | $140.0M | $205.6M | ||
| Q2 25 | $146.8M | $203.1M | ||
| Q1 25 | $142.0M | $193.6M | ||
| Q4 24 | $145.3M | $215.7M | ||
| Q3 24 | $143.4M | $196.6M | ||
| Q2 24 | $152.0M | $198.6M | ||
| Q1 24 | $152.0M | $188.6M |
净利润FATOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-58.2M | $-22.8M | ||
| Q2 25 | $-54.2M | $-14.1M | ||
| Q1 25 | $-46.0M | $-53.1M | ||
| Q4 24 | $-67.4M | $-29.1M | ||
| Q3 24 | $-44.8M | $-27.4M | ||
| Q2 24 | $-39.4M | $-33.4M | ||
| Q1 24 | $-38.3M | $-36.0M |
毛利率FATOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率FATOFIX
| Q4 25 | — | 0.2% | ||
| Q3 25 | -12.4% | -8.3% | ||
| Q2 25 | -10.6% | -7.9% | ||
| Q1 25 | -6.0% | -25.2% | ||
| Q4 24 | -27.1% | -5.3% | ||
| Q3 24 | -6.2% | -9.6% | ||
| Q2 24 | -1.8% | -12.5% | ||
| Q1 24 | -0.9% | -15.6% |
净利率FATOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | -41.6% | -11.1% | ||
| Q2 25 | -36.9% | -6.9% | ||
| Q1 25 | -32.4% | -27.4% | ||
| Q4 24 | -46.4% | -13.5% | ||
| Q3 24 | -31.2% | -13.9% | ||
| Q2 24 | -25.9% | -16.8% | ||
| Q1 24 | -25.2% | -19.1% |
每股收益（稀释后）FATOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-3.39 | $-0.57 | ||
| Q2 25 | $-3.17 | $-0.36 | ||
| Q1 25 | $-2.73 | $-1.35 | ||
| Q4 24 | $-4.06 | $-0.76 | ||
| Q3 24 | $-2.74 | $-0.71 | ||
| Q2 24 | $-2.43 | $-0.88 | ||
| Q1 24 | $-2.37 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $82.0M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $-585.8M | $450.0M |
| 总资产 | $1.2B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FATOFIX
| Q4 25 | — | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $27.0M |
总债务FATOFIX
| Q4 25 | — | — | ||
| Q3 25 | $1.3B | $157.2M | ||
| Q2 25 | $1.3B | $157.0M | ||
| Q1 25 | $1.3B | $156.9M | ||
| Q4 24 | $1.3B | $157.0M | ||
| Q3 24 | $1.2B | $118.5M | ||
| Q2 24 | $1.2B | $118.0M | ||
| Q1 24 | $1.2B | $118.2M |
股东权益FATOFIX
| Q4 25 | — | $450.0M | ||
| Q3 25 | $-585.8M | $442.5M | ||
| Q2 25 | $-536.5M | $458.3M | ||
| Q1 25 | $-493.9M | $458.3M | ||
| Q4 24 | $-455.7M | $503.1M | ||
| Q3 24 | $-386.1M | $525.9M | ||
| Q2 24 | $-338.6M | $546.0M | ||
| Q1 24 | $-296.8M | $570.3M |
总资产FATOFIX
| Q4 25 | — | $850.6M | ||
| Q3 25 | $1.2B | $832.6M | ||
| Q2 25 | $1.2B | $837.2M | ||
| Q1 25 | $1.3B | $823.1M | ||
| Q4 24 | $1.3B | $893.3M | ||
| Q3 24 | $1.3B | $867.9M | ||
| Q2 24 | $1.4B | $882.0M | ||
| Q1 24 | $1.4B | $906.0M |
负债/权益比FATOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.5M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $-16.9M | $16.8M |
| 自由现金流率自由现金流/营收 | -12.1% | 7.6% |
| 资本支出强度资本支出/营收 | 1.7% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-75.0M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FATOFIX
| Q4 25 | — | $27.7M | ||
| Q3 25 | $-14.5M | $12.4M | ||
| Q2 25 | $-26.9M | $11.6M | ||
| Q1 25 | $-13.2M | $-18.4M | ||
| Q4 24 | $-10.4M | $23.7M | ||
| Q3 24 | $-3.2M | $11.7M | ||
| Q2 24 | $-14.2M | $9.0M | ||
| Q1 24 | $-28.4M | $-18.6M |
自由现金流FATOFIX
| Q4 25 | — | $16.8M | ||
| Q3 25 | $-16.9M | $2.5M | ||
| Q2 25 | $-29.3M | $4.5M | ||
| Q1 25 | $-17.8M | $-25.1M | ||
| Q4 24 | $-11.0M | $15.2M | ||
| Q3 24 | $-11.1M | $6.3M | ||
| Q2 24 | $-24.4M | $-360.0K | ||
| Q1 24 | $-32.5M | $-29.1M |
自由现金流率FATOFIX
| Q4 25 | — | 7.6% | ||
| Q3 25 | -12.1% | 1.2% | ||
| Q2 25 | -20.0% | 2.2% | ||
| Q1 25 | -12.5% | -13.0% | ||
| Q4 24 | -7.6% | 7.0% | ||
| Q3 24 | -7.7% | 3.2% | ||
| Q2 24 | -16.1% | -0.2% | ||
| Q1 24 | -21.4% | -15.4% |
资本支出强度FATOFIX
| Q4 25 | — | 4.9% | ||
| Q3 25 | 1.7% | 4.8% | ||
| Q2 25 | 1.6% | 3.5% | ||
| Q1 25 | 3.2% | 3.5% | ||
| Q4 24 | 0.4% | 4.0% | ||
| Q3 24 | 5.5% | 2.7% | ||
| Q2 24 | 6.7% | 4.7% | ||
| Q1 24 | 2.7% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FAT
| Restaurant Sales | $96.6M | 69% |
| Royalty | $21.6M | 15% |
| Factory | $9.6M | 7% |
| Advertising | $9.1M | 7% |
| Franchisor | $1.5M | 1% |
| Other | $1.5M | 1% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
